from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1388/mihF

LFCtreatmentdescriptionclass of inhibitor

-0.360

Amikacinug/mL Amikacintranslation

0.937

Cap5-10ug/mL Capreomycintranslation

0.029

Rox10-50 ug/mL Roxithromycintranslation

0.503

SM2-5 ug/mL Streptomycintranslation

-0.674

Tet5-10 ug/mL Tetracyclinetranslation

0.814

Rif0.2-5ug/mL Rifampicintranscription

0.462

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.706

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.354

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.657

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.399

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.506

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.039

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.546

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.777

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.159

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.477

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.560

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.555

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.766

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.155

KCN5-20 ug/mL Potassium cyaniderespiration

-0.989

NaN30.2-2 mM Sodium aziderespiration

0.741

Nigericin50 uM Nigericinrespiration

0.242

TRC10-150 ug/mL Triclosanrespiration

-0.810

TRZ10-25 ug/mL Thioridazinerespiration

3.641

Valinomycin0.5-10 uM Valinomycinrespiration

0.358

ZnSO42 mM ZnSO4respiration

-0.521

menadione6-10 ug/mL Menadionerespiration

-0.518

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.616

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.125

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.446

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.295

NRP_1Non-replicating persistence stage 1dosRassociated

0.265

Amp0.2mg/mL AmpicillincellWall

-0.106

Cephalexin20-100 ug/mL CephalexincellWall

0.335

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.308

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.127

EMB10-20 ug/mL EthambutolcellWall

-0.362

Eta12-40 ug/mL EthionamidecellWall

-0.646

INH0.2-0.4 ug/mL IsoniazidcellWall

0.027

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.647

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.392

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.601

BZA0.12 mg/mL BenzamidearomaticAmides

0.562

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.121

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.555

H2O24 mM hydrogen peroxideDNAdamaging

0.230

Levo10 ug/mL LevofloxacinDNAdamaging

0.367

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.406

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.277

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.218

UVUV-irradiationDNAdamaging

0.635

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.277

Antimycin12.5-50 ug/mL Antimycin A?

-0.226

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.403

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.273

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.027

PA8240.2-2 ug/mL PA-824?

0.094

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.215

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.055

Verapamil50 uM Verapamil?

0.130

mercaptoethanol2 mM 2-Mercaptoethanol?

0.465

methoxatin10-20 ug/mL Methoxatin?